Controversially, it has been demonstrated that zinc carboxylate, evaluated towards acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), displayed high inhibitory activity having a strong potency to block cognitive decline in Alzheimer’s disease [12]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.